Lv2
140 积分 2024-09-13 加入
Liver-specific actions of GH and IGF1 that protect against MASLD
1天前
已完结
RYK is a GPNMB receptor that drives MASH
14天前
已完结
GLP ‐ 1R biased cAMP agonism maintains glycemic control with reduced malaise and emesis in preclinical mammalian models
16天前
已完结
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
3个月前
已完结
Discovery and pharmacology of the covalent GLP-1 receptor (GLP-1R) allosteric modulator BETP: A novel tool to probe GLP-1R pharmacology
4个月前
已完结
Design, synthesis, and structure-activity relationship study of novel GLP-1/GIP/GCG triple receptor agonists
4个月前
已完结
Glucagon and GLP-1 receptor dual agonist survodutide improved liver histology in people with MASH and fibrosis: Results from a randomized, double-blind, placebo-controlled phase 2 trial
4个月前
已完结
Adipose tissue ageing: implications for metabolic health and lifespan
6个月前
已完结
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH
7个月前
已完结
Semaglutide and Tirzepatide to Treat Obesity
8个月前
已完结
皖公网安备34019202002308
